BNP Paribas Financial Markets
UBX

BNP Paribas Financial Markets’s Unity Biotechnology UBX Stock Holding History

BNP Paribas Financial Markets’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3
Closed -$1 – 5784
2025
Q2 		$1 Hold
3
– – ﹤0.01% 5431
2025
Q1 		$3 Hold
3
– – ﹤0.01% 5362
2024
Q4 		$3 Buy
+3
New +$4 ﹤0.01% 5383
2022
Q4 		– Sell
-7
Closed -$29 – 4621
2022
Q3 		$29 Hold
7
– – ﹤0.01% 4687
2022
Q2 		$42 Hold
7
– – ﹤0.01% 4041
2022
Q1 		$83 Sell
7
-41
-85% -$460 ﹤0.01% 4100
2021
Q4 		$704 Buy
48
+39
+433% +$852 ﹤0.01% 4083
2021
Q3 		$264 Sell
9
-21
-70% -$741 ﹤0.01% 3945
2021
Q2 		$1.38K Sell
30
-425
-93% -$20.5K ﹤0.01% 3919
2021
Q1 		$27.3K Sell
455
-200
-31% -$13.6K ﹤0.01% 3712
2020
Q4 		$34.3K Sell
655
-138
-17% -$6.65K ﹤0.01% 3705
2020
Q3 		$27.4K Buy
793
+672
+555% +$42.6K ﹤0.01% 3720
2020
Q2 		$10.5K Sell
121
-766
-86% -$56.8K ﹤0.01% 3684
2020
Q1 		$51.5K Buy
887
+550
+163% +$34.7K ﹤0.01% 3525
2019
Q4 		$24.3K Sell
337
-72
-18% -$5.08K ﹤0.01% 3944
2019
Q3 		$24.9K Buy
409
+130
+47% +$9.2K ﹤0.01% 3851
2019
Q2 		$26.5K Sell
279
-257
-48% -$21.9K ﹤0.01% 3794
2019
Q1 		$43.4K Buy
536
+527
+5,856% +$59.8K ﹤0.01% 3586
2018
Q4 		$1.46K Sell
9
-8
-47% -$1.06K ﹤0.01% 3859
2018
Q3 		$2.69K Buy
+17
New +$2.8K ﹤0.01% 4217

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

BNP Paribas Financial Markets's UBX Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 3 shares — an estimated $1 sold.

BNP Paribas Financial Markets first reported a position in UBX in Q3 2018 and held it in 20 quarters. The position peaked at $51.5K in Q1 2020. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 3 Unity Biotechnology shares in Q3 2025, an estimated $1.
  • BNP Paribas Financial Markets first reported a position in Unity Biotechnology in Q3 2018 and held it in 20 quarters.
  • BNP Paribas Financial Markets's Unity Biotechnology position peaked at $51.5K in Q1 2020.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.